Drugs & TargetsFree Morphotek and Targeted Alpha Therapy Group to collaborate in ovarian cancer December 04, 2015Vol.41 No.44
Drugs & TargetsFree European Commission grants marketing authorization for Kyprolis in multiple myeloma December 04, 2015Vol.41 No.44
Drugs & TargetsFree MD Anderson and Boehringer Ingleheim announce collaboration December 04, 2015Vol.41 No.44
Drugs & Targets FDA Approves Ninlaro and Darzalex For the Treatment of Multiple Myeloma November 30, 2015Vol.38 No.11
Drugs & Targets Eli Lilly and Merck extend phase III Alimta-Keytruda study collaboration November 20, 2015Vol.41 No.43
Drugs & Targets Ninlaro first protesome inhibitor approved in multiple myeloma November 20, 2015Vol.41 No.43
Drugs & Targets Approvals Granted to Darzalex and Ninlaro in Multiple Myeloma November 20, 2015Vol.41 No.43
Drugs & Targets Tagrisso Granted Accelerated Approval in Non-Small Cell Lung Cancer November 13, 2015Vol.41 No.42
